Report copyright - Presentación de PowerPoint - REVISIONESENCANCER...Ph III CTs IT 1st line NSCLC 8 –12 febrero Metastatic St IV NSCL 1st line therapy Non-Squamous No genomic target PD-L1 < 1 %
Please pass captcha verification before submit form
Please pass captcha verification before submit form